Mesirow Financial Investment Management, Inc. Red Hill Biopharma Ltd. Transaction History

Mesirow Financial Investment Management, Inc.

  • $4.94 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 23, 2021
SELL
$5.98 - $7.51 $10,530 - $13,225
-1,761 Closed
0 $0
Q1 2021

Apr 14, 2021
BUY
$6.98 - $11.29 $5,262 - $8,512
754 Added 74.88%
1,761 $13,000
Q4 2020

Jan 14, 2021
BUY
$7.81 - $10.39 $7,864 - $10,462
1,007 New
1,007 $8,000

Others Institutions Holding RDHL

# of Institutions
2
Shares Held
40.4K
Call Options Held
0
Put Options Held
0
View Full List

About RedHill Biopharma Ltd.

RDHL Quotes by TradingView
  • Ticker RDHL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 63,823,500
  • Market Cap $465M
  • Description
  • RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...
More about RDHL
Track This Portfolio

Track Mesirow Financial Investment Management, Inc. Portfolio

Follow Mesirow Financial Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mesirow Financial Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mesirow Financial Investment Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email